MustGrow Biologics (TSXV:MGRO) Short-Term Debt: C$0.38 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:MGRO MustGrow Biologics Corp TSXV:MGRO
26 GF Score
Price C$0.40
GF Value C$0.82
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is MustGrow Biologics Short-Term Debt?

MustGrow Biologics TSXV:MGRO -2.44% 26 Short-Term Debt is C$0.38 Mil as of Jun. 2026. GuruFocus rates TSXV:MGRO with a GF Score™ of 26/100 and a GF Value™ of C$0.82 (Possible Value Trap). The stock has 2 warning signs investors should review.

MustGrow Biologics's Short-Term Debt for the quarter that ended in Jun. 2026 was C$0.38 Mil.

MustGrow Biologics's quarterly Short-Term Debt stayed the same from Dec. 2025 (C$0.42 Mil) to Mar. 2026 (C$0.42 Mil) but then declined from Mar. 2026 (C$0.42 Mil) to Jun. 2026 (C$0.38 Mil).

MustGrow Biologics's annual Short-Term Debt declined from Dec. 2023 (C$0.62 Mil) to Dec. 2024 (C$0.39 Mil) but then increased from Dec. 2024 (C$0.39 Mil) to Dec. 2025 (C$0.42 Mil).

MustGrow Biologics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

MustGrow Biologics Short-Term Debt Related Terms

MustGrow Biologics Short-Term Debt Historical Data

* Premium members only.

The historical data trend for MustGrow Biologics's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MustGrow Biologics Short-Term Debt Chart

MustGrow Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.40 0.62 0.39 0.42

MustGrow Biologics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.42 0.42 0.42 0.38
TSXV:MGRO
26GF Score
MustGrow Biologics Corp TSXV:MGRO
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of C$0.38 Mil mean?
MustGrow Biologics (TSXV:MGRO) has a Short-Term Debt of C$0.38 Mil as of Jun. 2026.
Is MustGrow Biologics' Short-Term Debt too high?
MustGrow Biologics' current Short-Term Debt is C$0.38 Mil. Overall, MustGrow Biologics has a GF Score™ of 26/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' Short-Term Debt compare to CTVA and CF?
MustGrow Biologics' Short-Term Debt of C$0.38 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for an Agriculture company?
A good Short-Term Debt depends on the Agriculture industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. MustGrow Biologics's current Short-Term Debt is C$0.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
Based on GuruFocus' analysis, MustGrow Biologics (TSXV:MGRO) is currently considered Possible Value Trap. The stock's GF Value™ is C$0.82, compared to a current price of C$0.40 — trading 51.2% below its estimated fair value. The current Short-Term Debt is C$0.38 Mil. MustGrow Biologics' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For MustGrow Biologics (TSXV:MGRO), the current Short-Term Debt is C$0.38 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MustGrow Biologics (TSXV:MGRO) Overvalued in 2026?

Based on GuruFocus' analysis, MustGrow Biologics stock appears to be undervalued. The current stock price of C$0.40 is trading 51.2% below its estimated GF Value™ of C$0.82. GuruFocus considers MustGrow Biologics to be Possible Value Trap.

Key valuation signals for TSXV:MGRO:

  • Short-Term Debt: C$0.38 Mil
  • GF Value™: C$0.82 vs. price of C$0.40 (51.2% below fair value)
  • GF Score™: 26/100 with 2 warning signs

No single metric tells the full story. See the TSXV:MGRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MustGrow Biologics Business Description

Other Exchanges MGROF:USA0C0:Germany
Address 1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
26GF Score

Get the complete analysis for TSXV:MGRO

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.40
Price
C$0.82
GF Value